Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 35053553 | PubTator, text mining | PubMed |
| The portrait of liver cancer is shaped by mitochondrial genetics. | Cell Rep | 2022 | 35045282 | PubTator, text mining | PubMed |
| Progression of skin lesions in Warburg-Cinotti syndrome. | JAAD Case Rep | 2022 | 35036505 | PubTator, text mining | PubMed |
| Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer. | Pathol Int | 2022 | 35020975 | PubTator, text mining | PubMed |
| A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature. | Brain Tumor Pathol | 2022 | 35018523 | PubTator, text mining | PubMed |
| A Protein Composite Neural Scaffold Modulates Astrocyte Migration and Transcriptome Profile. | Macromol Biosci | 2022 | 35014754 | PubTator, text mining | PubMed |
| Detection and analysis of long noncoding RNA expression profiles related to epithelial-mesenchymal transition in keloids. | Biomed Eng Online | 2022 | 35012558 | PubTator, text mining | PubMed |
| The Functional Role of Extracellular Matrix Proteins in Cancer. | Cancers (Basel) | 2022 | 35008401 | PubTator, text mining | PubMed |
| Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers. | Curr Res Pharmacol Drug Discov | 2022 | 35005612 | PubTator, text mining | PubMed |
| Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer. | Gynecol Oncol Rep | 2022 | 35005155 | PubTator, text mining | PubMed |
| Regulation of Src tumor activity by its N-terminal intrinsically disordered region. | Oncogene | 2022 | 34999732 | PubTator, text mining | PubMed |
| Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. | Transl Oncol | 2022 | 34998236 | PubTator, text mining | PubMed |
| Ultrasensitive analysis of genetic instability related to chemical exposure. | J Appl Genet | 2022 | 34967917 | PubTator, text mining | PubMed |
| Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma. | EMBO Mol Med | 2022 | 34957688 | PubTator, text mining | PubMed |
| HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization | Balkan Med J | 2022 | 34928234 | PubTator, text mining | PubMed |
| Upregulated SLC27A2/FATP2 in differentiated thyroid carcinoma promotes tumor proliferation and migration. | J Clin Lab Anal | 2022 | 34854499 | PubTator, text mining | PubMed |
| Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors. | Cancer Med | 2022 | 34841742 | PubTator, text mining | PubMed |
| The extracellular matrix of hematopoietic stem cell niches. | Adv Drug Deliv Rev | 2022 | 34838648 | PubTator, text mining | PubMed |
| Liquid biopsy: Novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors. | Mol Clin Oncol | 2022 | 34824841 | PubTator, text mining | PubMed |
| Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis. | Acta Pharmacol Sin | 2022 | 34819618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=36